✦ LIBER ✦

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

✍ Scribed by D.Scott McMeekin; Alan Gordon; Jeffrey Fowler; Allen Melemed; Richard Buller; Thomas Burke; Jeffery Bloss; Paul Sabbatini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of echinomycin in patient

✍ Scott Wadler, Laura Tenteromano, Lorraine Cazenave… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 729 KB

Phase II study of carboplatin in patient

✍ F.H van Wijk; C Lhommé; G Bolis; V Scotto di Palumbo; S Tumolo; M Nooij; C.F de 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A Phase II Trial of Topotecan in Patient

✍ David Scott Miller; John A. Blessing; Samuel S. Lentz; Steven E. Waggoner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II trial of cisplatin as first-lin

✍ Jt Thigpen; JA Blessing; H Homesley; WT Creasman; G Sutton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB